🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is designed to assess the tolerability, safety, pharmacokinetic ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-05-20
Trial ID
NCT06938880
Treatments Being Tested
This study aims to evaluate the efficacy and safety of QLS31905 and/or QL17...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-06-30
Trial ID
NCT06446388
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
This is a prospective single-arm exploratory clinical study. The efficacy a...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2023-08-01
Trial ID
NCT05624099
Treatments Being Tested
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
Cerebral vasospasm is a common and serious complication after aneurysmal su...
Status
Recruiting
Location
Beijing Tiantan Hospital
Start Date
2026-06-03
Trial ID
NCT07643922
Treatments Being Tested
A surveillance of respiratory tract related adverse events in patients trea...
Status
Completed
Location
Cardiovascular Associates, P.C.
Start Date
2010-12
Trial ID
NCT01266265
Standard treatment of metastatic colorectal cancers relies on fluoropyrimid...
Status
Completed
Location
Centre Georges François Leclerc
Start Date
2010-12-15
Trial ID
NCT01348412
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested